Chloe Botaine

The traditional method of identifying unknown chemicals in medical devices has relied on a precarious game of structural "look-alikes" that often misses the mark by an order of magnitude. In pharmaceutical and medical device manufacturing, ensuring that products are free from harmful Extractables

The rapid evolution of generative artificial intelligence has fundamentally altered the accessibility of complex biological data, raising urgent concerns among developers about the potential for these tools to be misused in the creation of dangerous pathogens. While AI companies have traditionally

In the rapidly evolving landscape of synthetic biology, the ability to control engineered cells with the same precision we use to adjust a thermostat is becoming a reality. Ivan Kairatov, a biopharma expert with a deep background in research and development, joins us to discuss a groundbreaking

A critical emergency room surgeon preparing for a delicate procedure suddenly finds the digital imaging system frozen, not by a common glitch but by a state-sponsored actor halfway across the globe. This scenario is no longer a fringe possibility but a persistent reality in the current landscape

The convergence of artificial intelligence and deep clinical expertise is currently redefining the boundaries of what is possible in the highly specialized field of oncology diagnostics. Memorial Sloan Kettering Cancer Center and SOPHiA GENETICS have entered into a strategic collaboration to launch

The industrial landscape of the American Midwest is undergoing a profound transformation as Ohio emerges as a primary center for advanced pharmaceutical production, fueled by a substantial $267 million investment from Hikma Pharmaceuticals. This massive infusion of capital serves as a cornerstone

The field of nuclear medicine is currently witnessing a transformative shift as researchers leverage advanced artificial intelligence to solve the long-standing challenge of unpredictable radiation absorption in cancer patients. Recent breakthroughs led by Dr. Amit Nautiyal and a dedicated team of

The integrity of global health security rests upon the unwavering commitment of scientists to follow the strict legal and safety protocols designed to prevent the accidental or intentional spread of dangerous pathogens; however, recent events have demonstrated that even high-level experts are not

The ability to monitor the precise journey of therapeutic cells within the human body has remained an elusive goal for decades, often forcing clinicians to rely on indirect markers to guess whether a treatment has reached its intended target. This lack of visibility represents a significant hurdle

Ivan Kairatov stands at the forefront of biopharmaceutical innovation, possessing a deep-seated understanding of how technology reshapes the patient experience from the laboratory to the living room. As the healthcare industry increasingly leans on artificial intelligence to bridge gaps in care,